Kazuhiro Tsuchiya Selected Research

Therapeutics

2/2014	Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary report.
6/2003	[Abnormal MR findings in the temporal lobe and basal ganglia along with vasospasm in a case of hemiballism associated with diabetes mellitus].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiro Tsuchiya Research Topics

Disease

4	Neoplasms (Cancer) 01/2023 - 05/2003
1	Lymphoma (Lymphomas) 01/2023
1	Intracranial Arterial Diseases 02/2022
1	Brain Neoplasms (Brain Tumor) 04/2014
1	Glioma (Gliomas) 02/2014
1	Astrocytoma (Pilocytic Astrocytoma) 02/2014
1	Glioblastoma (Glioblastoma Multiforme) 02/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Amnesia (Dissociative Amnesia) 06/2003
1	Hyperglycemia 06/2003
1	Coma (Comas) 06/2003
1	Meningioma (Meningiomas) 05/2003

Drug/Important Bio-Agent (IBA)

2	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 02/2014
2	Coloring Agents (Dyes)IBA 02/2004 - 05/2003
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	MethyltransferasesIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 02/2014
1	gadoteridol (Prohance)FDA Link 01/2013
1	GadoliniumIBA 01/2013
1	Contrast MediaIBA 01/2013
1	Insulin (Novolin)FDA Link 06/2003
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2003
1	Blood Glucose (Blood Sugar)IBA 06/2003

Therapy/Procedure

3	Radiotherapy 01/2023 - 02/2014
2	Therapeutics 02/2014 - 06/2003
1	Stents 02/2022